S. Lapertosa

Registry of people with diabetes in three Latin American countries: a suitable approach to evaluate the quality of health care provided to people with type 2 diabetes

P. Aschner, J. Gagliardino, C. Faingold, 2013, International journal of clinical practice.

Ability of TyG Index as a Marker of Insulin Resistance in Argentinean School Children

C. Molinari, V. Hirschler, Claudio D. González, 2022, Frontiers in Pediatrics.

Use of cross-reactivity immunoassay to orient insulin replacement in diabetic patients with high levels of insulin antibodies

S. Lapertosa, E. Poskus, G. Frechtel, 2016, MethodsX.

Cardiometabolic markers among Argentinean normal weight and overweight children with and without central obesity

C. Molinari, V. Hirschler, G. Maccallini, 2021, Endocrine connections.

Adiposity, Lifestyle Behaviors, and Cardiometabolic Markers in Argentinean Schoolchildren.

C. Molinari, V. Hirschler, Claudio D. González, 2020, Clinica chimica acta; international journal of clinical chemistry.

Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR)

J. Gagliardino, E. Rucci, L. González, 2013, Diabetic medicine : a journal of the British Diabetic Association.

PRODIACOR: a patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina: study design and baseline data.

J. Gagliardino, J. Caporale, C. González, 2007, Contemporary clinical trials.

Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR)

C. Clark, J. Caporale, E. Rucci, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Influence of Telemedicine on the Number of Visits and HbA1c Determinations in Latin American Children with Type 1 Diabetes.

C. Molinari, V. Hirschler, Claudio D. González, 2021, Diabetes technology & therapeutics.